REGISTER BY 31ST JANUARY AND SAVE £400;
REGISTER BY 28TH FEBRUARY AND SAVE £200;
REGISTER BY 31ST MARCH AND SAVE £100
Created with an expert scientific advisory board, SMi’s 17th annual Pain Therapeutics conference will hone in on the latest innovations and novel approaches to pain therapy and analgesic drugs as well as look at the practicalities of using animal models and translational biomarkers in pain research.
Aimed at an audience of scientific leaders and senior specialists in neuroscience, CNS, clinical operations and pharmacology, Pain Therapeutics 2017 will keep attendees at the forefront of medical breakthroughs to adapt to the growing need towards minimising opioid dependency and furthering new drug discovery.
Presentations from a selection of hand-picked pharmaceutical companies currently developing novel treatments for pain will provide delegates with an understanding of key topics such as product formulation; opioid addiction; translational pain research; and breakthroughs in drug discovery.
Interactive workshops and exclusive new findings from phase II clinical trials will be just some of the highlights at the 17th annual show when it returns to London this spring.
KEYNOTE SPEAKERS INCLUDE:
Prof Anthony Jones, Professor of Neuro-Rheumatology, University of Manchester
Dr Steven Kamerling, Therapeutic Area Head for Pain, Inflammation and Oncology, Zoetis
Dr Joseph W. Stauffer, Chief Medical Officer, Cara Therapeutics Inc
Dr Stephen Doberstein, Senior Vice President and Chief Scientific Officer, Nektar Pharmaceuticals
Dr Iain Chessell, Head of Neuroscience, AstraZeneca
Dr Randall Stevens, Chief Medical Officer, Centrexion Therapeutics Corp
Dr Richard Butt, Chief Executive Officer, Apollo Therapeutics
Prof Theo Meert, Head of Global Government Grant Office, Janssen Pharmaceutica NV
Dr Narender Gavva, Scientific Director, Amgen
Dr Thomas Christoph, Head of Pharmacology and Biomarker Development, Grunenthal GmbH
Dr Ian Bell, Principal Scientist, MSD, USA
The packed agenda also features talks from Lilly UK, Novartis, Pharmaleads, Mundipharma Research and more!
Do you have a question you'd like the community to weigh in on? Maybe you'd like to ask your colleagues about the best experimental techniques to use in the lab, how to improve clinical care, or even about unpublished data? Now you can with PRF's new Q & A feature. Steve Davidson, U of Cincinnati, and Jeffrey Petruska, U of Louisville, have each posed a question--one about place preference boxes, the other about local anesthetics--to get things started. We'd love to hear what you have to say! Read more here.